An Introduction To The Cder Quantitative Medicine Center Of Excellence

An Introduction to the CDER Quantitative Medicine Center of Excellence

U.S. Food and Drug Administration

Bioanalytical Inspections: Overview and Case Studies – June 17, 2019

U.S. Food and Drug Administration

Module 8 – Part 1: Introduction to Digital Health

U.S. Food and Drug Administration

Oncology Center of Excellence Introduction and Overview of the Oncology Therapy Development Workshop

U.S. Food and Drug Administration

Introduction to the MIDD Training Course

U.S. Food and Drug Administration

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

U.S. Food and Drug Administration

Module 4 - Case Study 6: Role of Modeling & Simulation in the Development of Pembrolizumab

U.S. Food and Drug Administration

FDA Oncology Center of Excellence’s Project Facilitate

U.S. Food and Drug Administration

Module 4 – Case Study 5 Pharmacometrics & QSP-Based Analysis to Guide GnRH Receptor Modulator Dev’t.

U.S. Food and Drug Administration

FDA Oncology Center of Excellence’s Project Facilitate

U.S. Food and Drug Administration

Module 8 – Part 4: Proposed Frameworks for Digital Health

U.S. Food and Drug Administration

Module 7 – Case Study 5: Application of PBPK Models in Eliglustat Clinical Development

U.S. Food and Drug Administration

5 Minutes statistics for clinical research - Quantitative and Qualitative Data

GCP-Mindset - All About Clinical Research

What is Precision Medicine?

U.S. Food and Drug Administration

Module 8 – Part 5: Real-World Data (RWD) & Real-World Evidence (RWE)

U.S. Food and Drug Administration

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

U.S. Food and Drug Administration

MIDD Training Module 4 – Case Study 2: Anti-Viral Kinetic Modeling

U.S. Food and Drug Administration

ARC Centre of Excellence in Convergent bio-Nano Science & Technology

Module 7 – Case Study 6: Caplacizumab Model-Based Dosing Recommendations in Pediatrics

U.S. Food and Drug Administration